Acurx Pharmaceuticals, Inc. SEC filings ACXP
Acurx Pharmaceuticals, Inc. has 245 filings in SEC EDGAR's recent list, going back to Apr 3, 2018. Its latest annual report, Form ARS, was filed on Sep 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 16, 2026 | Oct 16, 2026 |
| EFFECT | Filing | Sep 17, 2026 | — |
| 424B3 | Prospectus | Sep 17, 2026 | — |
| S-1 | Registration statement | Sep 8, 2026 | — |
| ARS | Annual report to shareholders | Sep 1, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Sep 1, 2026 | — |
| DEF 14A | Proxy statement | Sep 1, 2026 | Oct 16, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 424B3 | Prospectus | May 12, 2026 | — |
| 424B3 | Prospectus | May 12, 2026 | — |
| EFFECT | Filing | May 11, 2026 | — |
| EFFECT | Filing | May 11, 2026 | — |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| CORRESP | Letter to the SEC | May 7, 2026 | — |
| CORRESP | Letter to the SEC | May 7, 2026 | — |
| UPLOAD | Letter from the SEC | May 7, 2026 | — |
| UPLOAD | Letter from the SEC | May 7, 2026 | — |
| S-1 | Registration statement | May 4, 2026 | — |
| S-1 | Registration statement | May 4, 2026 | — |
| D | Filing | Apr 29, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 16, 2026 | Apr 15, 2026 |
| 424B5 | Prospectus supplement | Apr 16, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 9, 2026 | Mar 9, 2026 |
| EFFECT | Filing | Feb 11, 2026 | — |
| 424B3 | Prospectus | Feb 11, 2026 | — |
| CORRESP | Letter to the SEC | Feb 9, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2026 | — |
| S-1 | Registration statement | Feb 2, 2026 | — |
| EFFECT | Filing | Jan 6, 2026 | — |
| CORRESP | Letter to the SEC | Jan 2, 2026 | — |
| S-3/A | Form s-3/a | Dec 30, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 424B3 | Prospectus | Nov 10, 2025 | — |
| S-1 | Registration statement | Oct 20, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 22, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 19, 2025 | Sep 16, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| DEFA14A | Additional proxy material | Aug 5, 2025 | — |
| DEF 14A | Proxy statement | Aug 4, 2025 | Sep 16, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jul 31, 2025 | Jul 31, 2025 |
| PRE 14A | Preliminary proxy statement | Jul 24, 2025 | Sep 16, 2025 |
| EFFECT | Filing | Jul 23, 2025 | — |
| CORRESP | Letter to the SEC | Jul 21, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jul 17, 2025 | Jul 17, 2025 |
| S-1 | Registration statement | Jul 15, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2025 | — |
| S-3 | Shelf registration | Jul 9, 2025 | — |
| D | Filing | Jun 27, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 20, 2025 | Jun 17, 2025 |
| EFFECT | Filing | May 29, 2025 | — |
| 424B3 | Prospectus | May 29, 2025 | — |
| ARS | Annual report to shareholders | May 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | May 29, 2025 | — |
| DEF 14A | Proxy statement | May 29, 2025 | Jul 17, 2025 |
| CORRESP | Letter to the SEC | May 27, 2025 | — |
| UPLOAD | Letter from the SEC | May 27, 2025 | — |
| S-1 | Registration statement | May 21, 2025 | — |
| D | Filing | May 20, 2025 | — |
| PRE 14A | Preliminary proxy statement | May 19, 2025 | Jul 17, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 8, 2025 | May 8, 2025 |
| EFFECT | Filing | Apr 14, 2025 | — |
| CORRESP | Letter to the SEC | Apr 10, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2025 | — |
| S-1 | Registration statement | Apr 4, 2025 | — |
| 8-K |
Current report
Listing notice
|
Mar 28, 2025 | Mar 25, 2025 |
| D | Filing | Mar 21, 2025 | — |
| EFFECT | Filing | Mar 19, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 18, 2025 | Mar 18, 2025 |
| S-8 | Employee stock plan registration | Mar 17, 2025 | — |
| POS AM | Filing | Mar 17, 2025 | — |
| 10-K | Annual report | Mar 17, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 10, 2025 | Mar 6, 2025 |
| 424B5 | Prospectus supplement | Mar 10, 2025 | — |
| 8-K |
Current report
Listing notice
|
Feb 26, 2025 | Feb 24, 2025 |
| EFFECT | Filing | Feb 6, 2025 | — |
| CORRESP | Letter to the SEC | Feb 4, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 4, 2025 | — |
| S-1 | Registration statement | Jan 31, 2025 | — |
| D | Filing | Jan 17, 2025 | — |
| 424B5 | Prospectus supplement | Jan 7, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 7, 2025 | Jan 6, 2025 |
| 424B3 | Prospectus | Jan 6, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2024 | Aug 9, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 17, 2024 |
| RW | Filing | Apr 17, 2024 | — |
| FWP | Free writing prospectus | Apr 2, 2024 | — |
| S-1/A | Amended registration statement | Mar 29, 2024 | — |
| 8-K |
Current report
Results of operations
|
Mar 18, 2024 | Mar 18, 2024 |
| S-1 | Registration statement | Mar 18, 2024 | — |
| S-8 | Employee stock plan registration | Mar 15, 2024 | — |
| 10-K | Annual report | Mar 15, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement
|
Nov 15, 2023 | Nov 15, 2023 |
| 424B5 | Prospectus supplement | Nov 15, 2023 | — |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Other events
|
Nov 3, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Other events
|
Oct 2, 2023 | Oct 2, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 424B3 | Prospectus | Jul 13, 2023 | — |
| EFFECT | Filing | Jul 10, 2023 | — |
| CORRESP | Letter to the SEC | Jul 6, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 5, 2023 | — |
| S-1 | Registration statement | Jun 29, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 20, 2023 | Jun 15, 2023 |
| 424B3 | Prospectus | May 18, 2023 | — |
| 424B5 | Prospectus supplement | May 17, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights
|
May 17, 2023 | May 16, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | Jun 15, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 16, 2023 | Mar 16, 2023 |
| S-8 | Employee stock plan registration | Mar 15, 2023 | — |
| 10-K | Annual report | Mar 15, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 424B3 | Prospectus | Sep 23, 2022 | — |
| EFFECT | Filing | Sep 22, 2022 | — |
| CORRESP | Letter to the SEC | Sep 20, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 19, 2022 | — |
| S-1 | Registration statement | Sep 14, 2022 | — |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 424B5 | Prospectus supplement | Jul 25, 2022 | — |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Jul 25, 2022 | Jul 25, 2022 |
| EFFECT | Filing | Jul 11, 2022 | — |
| CORRESP | Letter to the SEC | Jul 7, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2022 | — |
| S-3 | Shelf registration | Jul 1, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 25, 2022 | — |
| DEF 14A | Proxy statement | Apr 25, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2022 | Mar 17, 2022 |
| S-8 | Employee stock plan registration | Mar 16, 2022 | — |
| 10-K | Annual report | Mar 16, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 16, 2021 | Nov 12, 2021 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 16, 2021 | Aug 16, 2021 |
| 10-Q | Quarterly report | Aug 13, 2021 | Jun 30, 2021 |
| S-8 | Employee stock plan registration | Jul 19, 2021 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jun 29, 2021 | Jun 23, 2021 |
| 424B4 | Prospectus | Jun 28, 2021 | — |
| EFFECT | Filing | Jun 24, 2021 | — |
| CERT | Filing | Jun 24, 2021 | — |
| 8-A12B | Filing | Jun 23, 2021 | — |
| CORRESP | Letter to the SEC | Jun 22, 2021 | — |
| CORRESP | Letter to the SEC | Jun 22, 2021 | — |
| FWP | Free writing prospectus | Jun 11, 2021 | — |
| S-1/A | Amended registration statement | Jun 11, 2021 | — |
| S-1 | Registration statement | May 27, 2021 | — |
| CORRESP | Letter to the SEC | May 26, 2021 | — |
| UPLOAD | Letter from the SEC | May 21, 2021 | — |
| DRSLTR | Filing | May 10, 2021 | — |
| DRS/A | Filing | May 10, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2021 | — |
| DRS | Filing | Apr 5, 2021 | — |
| D | Filing | Jan 17, 2020 | — |
| D/A | Filing | Oct 30, 2019 | — |
| D/A | Filing | Oct 30, 2018 | — |
| D/A | Filing | May 31, 2018 | — |
| D | Filing | Apr 3, 2018 | — |
Showing 179 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACXP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Staten Island, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1736243
- Former names
- Acurx Pharmaceuticals, LLC (until Jun 23, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.